Published 2 years ago

Coronavirus: Annual vaccine preferable to frequent boosters, says Pfizer

Summary by Ground News

Head of drug company Pfizer says an annual Covid-19 vaccine would be preferable to more frequent booster shots. Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March. US Centers for Disease Control and Prevention (CDC) said on Friday that a third dose of an mRNA vaccine is key to fighting O Micron.

0 Articles

All

Left

Center

Right

Reuters

Coronavirus: Annual vaccine preferable to frequent boosters, says Pfizer

Pfizer Inc CEO Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in the fight against the coronavirus pandemic.

2 years ago·United Kingdom

Read Full Article

RNZ

Pfizer CEO sees annual Covid vaccine rather than frequent boosters

The head of drug company Pfizer says an annual Covid-19 vaccine would be preferable to more frequent booster shots.

2 years ago·New Zealand

Read Full Article

KSL

Pfizer CEO sees annual COVID vaccine rather than frequent boosters

Pfizer Chief Executive Albert Bourla said on Saturday that an annual COVID-19 vaccine would be preferable to more frequent booster shots in fighting the coronavirus pandemic.

2 years ago·Salt Lake City, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.